Prodrug photolysis enables spatiotemporal control of drug release at the desired lesions. For photoactivated therapy, near-infrared (NIR) light is preferable due to its deep tissue penetration and low phototoxicity. However, most of the photocleavable groups cannot be directly activated by NIR light. Here, we report a upconversion-like process via only one step of energy transfer for NIR light-triggered prodrug photolysis. We utilize a photosensitizer (PS) that can be activated via singlet-triplet (S-T) absorption and achieve photolysis of boron-dipyrromethene (BODIPY)-based prodrugs via triplet-triplet energy transfer. Using the strategy, NIR light can achieve green light-responsive photolysis with a single-photon process. A wide range of drugs and bioactive molecules are designed and demonstrated to be released under low-irradiance NIR light (100 mW/cm2, 5 min) with high yields (up to 87%). Moreover, a micellar nanosystem encapsulating both PS and prodrug is developed to demonstrate the practicality of our strategy in normoxia aqueous environment for cancer therapy. This study may advance the development of photocleavable prodrugs and photoresponsive drug delivery systems for photo-activated therapy.
1 February 2023 in Journal of Materials Chemistry C
Chiral organic–inorganic hybrid metal halides with high photoluminescence quantum yield (PLQY) and high luminescence dissymmetry factor (glum) offer a new platform for multifunctional photoelectric applications. Herein, we report two pairs of chiral organic–inorganic hybrid manganese(II) halide clusters (R/S-3-aminopyrrolidine dihydrochloride)6(Mn3Cl12)(Cl)6 (R/S-1) and (R/S-1,2-diaminopropane dihydrochloride)3(Mn3Cl12) (R/S-2). Both of them have high PLQY (more than 42%) under ambient conditions; in particular, the PLQY of R/S-2 reached 85%. More importantly, the glum value of R/S-1 (|glum| = 0.0071) is 3.5 times that of R/S-2 (|glum| = 0.002), showing excellent circularly polarized luminescence (CPL) properties. Through the structural analysis of single crystals, we reveal that the directional arrangement of chiral ligands in manganese cluster molecules has the ability to amplify the CPL properties. Furthermore, based on the excellent luminescence properties of R/S-2, we show examples of their applications as scintillators in X-ray detection and imaging. To our knowledge, this is the first report of chiral manganese(II) halide scintillators. This research provides rational guiding principles for the design and preparation of multifunctional chiral organic–inorganic hybrid metal halides.
We have designed and synthesized a new B- and N-embedded asymmetric heteroleptic phosphorescent iridium(III) complex IrBNacac with ambipolar characteristics. The X-ray diffraction technique shows that the two B- and N-embedded π-conjugation units in the complex exhibit good planarity and induce rich π–π interactions in the crystal state. More importantly, it exhibits an effective red emission (623 nm) in the thin film state with a very narrow full width at half maximum (FWHM = 50 nm, 0.158 eV), even narrower than that of model complexes (53 nm, 0.162 eV for IrBBacac and 62 nm, 0.224 eV for IrNNacac). DFT calculation shows that the lowest excited triplet state (T1) of the complex IrBNacac exhibits richer excited state characteristics than those of the model complexes, including a charge transfer transition from the N-embedded ligand to the B-embedded ligand (3LLCT) and a metal-to-ligand charge transfer transition (3MLCT), along with an intraligand charge transfer (3ILCT). Considering the good photophysical properties and solubility, the red-emitting complex IrBNacac was used as the emitting layer of a solution-processed OLED device and showed good maximum external quantum efficiency (EQE) (4.9%) peaking at 625 nm with the CIE coordinates (0.64, 0.35), accompanied by a low turn-on voltage. This research provides an important strategy for the design of narrowband red-emitting phosphorescent iridium complexes and their optoelectronic applications.
The development of innovative synergistic phototherapy (SPT) agent with excellent photodynamic therapy (PDT) and photothermal therapy (PTT) effects for efficient antitumor is of great significance. However, the low photothermal conversion efficiency or low singlet oxygen yield of SPT agent during the phototherapy process will result in inefficient tumor therapy. Herein, a new near‐infrared (NIR) SPT agent based on aza‐platinum‐dipyrromethene dye (D‐3) with synergistic PDT and PTT effects is rationally designed and synthesized by the metallization and halogenation of aza‐dipyrromethene simultaneously. The introduction of iodine atoms and Pt(II) ion to aza‐dipyrromethene skeleton can not only effectively promote the excited electrons to undergo intersystem crossing process for improving singlet oxygen (1O2) generation capability, but also inhibit radiative transition process for boosting photothermal conversion properties. For biological exploration, the biocompatible D‐3 nanomaterials (APIDNs) with excellent concentration‐dependent photoacoustic and photothermal properties are prepared, thus visibly guiding synergetic PDT and PTT effects for inhibiting the growth of tumor cells in vivo. This work demonstrates the superior therapy effects of APIDNs and its negligible dark cytotoxicity. The novel strategy reported in this work will offer a new way to design new‐generation NIR aza‐metal‐dipyrromethene‐based dyes for developing superior SPT agents.